Psilera's New Psychedelic Compounds: A Non-Hallucinogenic Promise For Depression And Neurodegenerative Disorders?
Next-generation R&D psychedelics company Psilera Inc. shared its two proprietary DMT analogs PSIL-001 and PSIL-002’s preclinical positive results for mental health disorder treatments.
